{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T01:50:14Z","timestamp":1794102614348,"version":"4.8.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,4,12]],"date-time":"2015-04-12T00:00:00Z","timestamp":1428796800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12885-015-1208-y","type":"journal-article","created":{"date-parts":[[2015,4,11]],"date-time":"2015-04-11T05:35:43Z","timestamp":1428730543000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["DNA methylation and histone modifications regulate SOX11 expression in lymphoid and solid cancer cells"],"prefix":"10.1186","volume":"15","author":[{"given":"Lena","family":"Nordstr\u00f6m","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elin","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venera","family":"Kuci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elin","family":"Gustavsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Holm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Ringn\u00e9r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Guldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Ek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,12]]},"reference":[{"issue":"8","key":"1208_CR1","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1002\/dvdy.21218","volume":"236","author":"JC Kiefer","year":"2007","unstructured":"Kiefer JC. Back to basics: Sox genes. Dev Dyn. 2007;236(8):2356\u201366.","journal-title":"Dev Dyn"},{"issue":"12","key":"1208_CR2","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1016\/j.biocel.2007.05.019","volume":"39","author":"V Lefebvre","year":"2007","unstructured":"Lefebvre V, Dumitriu B, Penzo-Mendez A, Han Y, Pallavi B. Control of cell fate and differentiation by Sry-related high-mobility-group box (Sox) transcription factors. Int J Biochem Cell Biol. 2007;39(12):2195\u2013214.","journal-title":"Int J Biochem Cell Biol"},{"issue":"6","key":"1208_CR3","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1002\/dvdy.23962","volume":"242","author":"Y Wang","year":"2013","unstructured":"Wang Y, Lin L, Lai H, Parada LF, Lei L. Transcription factor Sox11 is essential for both embryonic and adult neurogenesis. Dev Dyn. 2013;242(6):638\u201353.","journal-title":"Dev Dyn"},{"issue":"3","key":"1208_CR4","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.biocel.2009.07.018","volume":"42","author":"AI Penzo-Mendez","year":"2010","unstructured":"Penzo-Mendez AI. Critical roles for SoxC transcription factors in development and cancer. Int J Biochem Cell Biol. 2010;42(3):425\u20138.","journal-title":"Int J Biochem Cell Biol"},{"issue":"7153","key":"1208_CR5","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nature06008","volume":"448","author":"TS Mikkelsen","year":"2007","unstructured":"Mikkelsen TS, Ku M, Jaffe DB, Issac B, Lieberman E, Giannoukos G, et al. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature. 2007;448(7153):553\u201360.","journal-title":"Nature"},{"issue":"2","key":"1208_CR6","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.cell.2006.02.041","volume":"125","author":"BE Bernstein","year":"2006","unstructured":"Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, Cuff J, et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell. 2006;125(2):315\u201326.","journal-title":"Cell"},{"key":"1208_CR7","doi-asserted-by":"publisher","first-page":"e204","DOI":"10.1038\/cddis.2011.84","volume":"2","author":"H Richly","year":"2011","unstructured":"Richly H, Aloia L, Di Croce L. Roles of the Polycomb group proteins in stem cells and cancer. Cell Death Dis. 2011;2:e204.","journal-title":"Cell Death Dis"},{"issue":"6","key":"1208_CR8","doi-asserted-by":"publisher","first-page":"e21382","DOI":"10.1371\/journal.pone.0021382","volume":"6","author":"MC Vegliante","year":"2011","unstructured":"Vegliante MC, Royo C, Palomero J, Salaverria I, Balint B, Martin-Guerrero I, et al. Epigenetic activation of SOX11 in lymphoid neoplasms by histone modifications. PLoS One. 2011;6(6):e21382.","journal-title":"PLoS One"},{"issue":"2","key":"1208_CR9","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/ng1950","volume":"39","author":"Y Schlesinger","year":"2007","unstructured":"Schlesinger Y, Straussman R, Keshet I, Farkash S, Hecht M, Zimmerman J, et al. Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nat Genet. 2007;39(2):232\u20136.","journal-title":"Nat Genet"},{"issue":"2","key":"1208_CR10","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/ng1719","volume":"38","author":"I Keshet","year":"2006","unstructured":"Keshet I, Schlesinger Y, Farkash S, Rand E, Hecht M, Segal E, et al. Evidence for an instructive mechanism of de novo methylation in cancer cells. Nat Genet. 2006;38(2):149\u201353.","journal-title":"Nat Genet"},{"issue":"1","key":"1208_CR11","first-page":"139","volume":"13","author":"B Weigle","year":"2005","unstructured":"Weigle B, Ebner R, Temme A, Schwind S, Schmitz M, Kiessling A, et al. Highly specific overexpression of the transcription factor SOX11 in human malignant gliomas. Oncol Rep. 2005;13(1):139\u201344.","journal-title":"Oncol Rep"},{"issue":"5","key":"1208_CR12","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1215\/15228517-2008-032","volume":"10","author":"JM de Bont","year":"2008","unstructured":"de Bont JM, Kros JM, Passier MMCJ, Reddingius RE, Smitt PAES, Luider TM, et al. Differential expression and prognostic significance of SOX genes in pediatric medulloblastoma and ependymoma identified by microarray analysis. Neuro-Oncology. 2008;10(5):648\u201360.","journal-title":"Neuro-Oncology"},{"issue":"2","key":"1208_CR13","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1182\/blood-2007-06-093401","volume":"111","author":"S Ek","year":"2008","unstructured":"Ek S, Dictor M, Jerkeman M, Jirstrom K, Borrebaeck CA. Nuclear expression of the non B-cell lineage Sox11 transcription factor identifies mantle cell lymphoma. Blood. 2008;111(2):800\u20135.","journal-title":"Blood"},{"issue":"11","key":"1208_CR14","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.3324\/haematol.2009.008474","volume":"94","author":"M Dictor","year":"2009","unstructured":"Dictor M, Ek S, Sundberg M, Warenholt J, Gyorgy C, Sernbo S, et al. Strong lymphoid nuclear expression of SOX11 transcription factor defines lymphoblastic neoplasms, mantle cell lymphoma and Burkitt\u2019s lymphoma. Haematologica. 2009;94(11):1563\u20138.","journal-title":"Haematologica"},{"issue":"8","key":"1208_CR15","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1016\/j.ejca.2009.01.028","volume":"45","author":"DJ Brennan","year":"2009","unstructured":"Brennan DJ, Ek S, Doyle E, Drew T, Foley M, Flannelly G, et al. The transcription factor Sox11 is a prognostic factor for improved recurrence-free survival in epithelial ovarian cancer. Eur J Cancer. 2009;45(8):1510\u20137.","journal-title":"Eur J Cancer"},{"issue":"2","key":"1208_CR16","doi-asserted-by":"publisher","first-page":"R25","DOI":"10.1186\/bcr3403","volume":"15","author":"M Zvelebil","year":"2013","unstructured":"Zvelebil M, Oliemuller E, Gao Q, Wansbury O, Mackay A, Kendrick H, et al. Embryonic mammary signature subsets are activated in Brca1-\/- and basal-like breast cancers. Breast Cancer Res. 2013;15(2):R25.","journal-title":"Breast Cancer Res"},{"key":"1208_CR17","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/1476-4598-9-187","volume":"9","author":"E Gustavsson","year":"2010","unstructured":"Gustavsson E, Sernbo S, Andersson E, Brennan DJ, Dictor M, Jerkeman M, et al. SOX11 expression correlates to promoter methylation and regulates tumor growth in hematopoietic malignancies. Mol Cancer. 2010;9:187.","journal-title":"Mol Cancer"},{"issue":"1","key":"1208_CR18","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/bjh.12854","volume":"166","author":"L Nordstr\u00f6m","year":"2014","unstructured":"Nordstr\u00f6m L, Sernbo S, Eden P, Gr\u00f8nb\u00e6k K, Kolstad A, R\u00e4ty R, et al. SOX11 and TP53 add prognostic information to MIPI in a homogenously treated cohort of mantle cell lymphoma \u2013 a Nordic Lymphoma Group study. Br J Haematol. 2014;166(1):98\u2013108.","journal-title":"Br J Haematol"},{"issue":"1","key":"1208_CR19","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/1475-2867-13-109","volume":"13","author":"S Zhang","year":"2013","unstructured":"Zhang S, Li S, Gao JL. Promoter methylation status of the tumor suppressor gene SOX11 is associated with cell growth and invasion in nasopharyngeal carcinoma. Cancer Cell Int. 2013;13(1):109.","journal-title":"Cancer Cell Int"},{"issue":"7","key":"1208_CR20","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1158\/1055-9965.EPI-11-0067","volume":"20","author":"W Chung","year":"2011","unstructured":"Chung W, Bondaruk J, Jelinek J, Lotan Y, Liang S, Czerniak B, et al. Detection of bladder cancer using novel DNA methylation biomarkers in urine sediments. Cancer Epidemiol Biomarkers Prev. 2011;20(7):1483\u201391.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"21","key":"1208_CR21","doi-asserted-by":"publisher","first-page":"4067","DOI":"10.1093\/bioinformatics\/bti652","volume":"21","author":"C Bock","year":"2005","unstructured":"Bock C, Reither S, Mikeska T, Paulsen M, Walter J, Lengauer T. BiQ Analyzer: visualization and quality control for DNA methylation data from bisulfite sequencing. Bioinformatics. 2005;21(21):4067\u20138.","journal-title":"Bioinformatics"},{"issue":"5","key":"1208_CR22","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.1093\/nar\/gkn083","volume":"36","author":"C Rohde","year":"2008","unstructured":"Rohde C, Zhang Y, Jurkowski TP, Stamerjohanns H, Reinhardt R, Jeltsch A. Bisulfite sequencing Data Presentation and Compilation (BDPC) web server\u2013a useful tool for DNA methylation analysis. Nucleic Acids Res. 2008;36(5):e34.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"1208_CR23","doi-asserted-by":"publisher","first-page":"771","DOI":"10.2217\/epi.11.105","volume":"3","author":"S Dedeurwaerder","year":"2011","unstructured":"Dedeurwaerder S, Defrance M, Calonne E, Denis H, Sotiriou C, Fuks F. Evaluation of the Infinium Methylation 450K technology. Epigenomics. 2011;3(6):771\u201384.","journal-title":"Epigenomics"},{"issue":"7414","key":"1208_CR24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature11247","volume":"489","author":"BE Bernstein","year":"2012","unstructured":"Bernstein BE, Birney E, Dunham I, Green ED, Gunter C, Snyder M. An integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489(7414):57\u201374.","journal-title":"Nature"},{"issue":"7","key":"1208_CR25","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1093\/clinchem\/47.7.1183","volume":"47","author":"J Worm","year":"2001","unstructured":"Worm J, Aggerholm A, Guldberg P. In-tube DNA methylation profiling by fluorescence melting curve analysis. Clin Chem. 2001;47(7):1183\u20139.","journal-title":"Clin Chem"},{"issue":"4","key":"1208_CR26","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1006\/meth.2001.1268","volume":"25","author":"BN Trinh","year":"2001","unstructured":"Trinh BN, Long TI, Laird PW. DNA methylation analysis by MethyLight technology. Methods. 2001;25(4):456\u201362.","journal-title":"Methods"},{"issue":"21","key":"1208_CR27","doi-asserted-by":"publisher","first-page":"6823","DOI":"10.1093\/nar\/gki987","volume":"33","author":"DJ Weisenberger","year":"2005","unstructured":"Weisenberger DJ, Campan M, Long TI, Kim M, Woods C, Fiala E, et al. Analysis of repetitive element DNA methylation by MethyLight. Nucleic Acids Res. 2005;33(21):6823\u201336.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"1208_CR28","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1186\/1471-2407-12-269","volume":"12","author":"L Nordstrom","year":"2012","unstructured":"Nordstrom L, Andreasson U, Jerkeman M, Dictor M, Borrebaeck C, Ek S. Expanded clinical and experimental use of SOX11 - using a monoclonal antibody. BMC Cancer. 2012;12(1):269.","journal-title":"BMC Cancer"},{"key":"1208_CR29","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1038\/srep01400","volume":"3","author":"AM Wasik","year":"2013","unstructured":"Wasik AM, Lord M, Wang X, Zong F, Andersson P, Kimby E, et al. SOXC transcription factors in mantle cell lymphoma: the role of promoter methylation in SOX11 expression. Sci Rep. 2013;3:1400.","journal-title":"Sci Rep"},{"issue":"9","key":"1208_CR30","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/j.bcp.2006.12.032","volume":"73","author":"JN Ou","year":"2007","unstructured":"Ou JN, Torrisani J, Unterberger A, Provencal N, Shikimi K, Karimi M, et al. Histone deacetylase inhibitor Trichostatin A induces global and gene-specific DNA demethylation in human cancer cell lines. Biochem Pharmacol. 2007;73(9):1297\u2013307.","journal-title":"Biochem Pharmacol"},{"issue":"19","key":"1208_CR31","doi-asserted-by":"publisher","first-page":"4119","DOI":"10.1128\/MCB.01304-10","volume":"31","author":"MK Arzenani","year":"2011","unstructured":"Arzenani MK, Zade AE, Ming Y, Vijverberg SJ, Zhang Z, Khan Z, et al. Genomic DNA hypomethylation by histone deacetylase inhibition implicates DNMT1 nuclear dynamics. Mol Cell Biol. 2011;31(19):4119\u201328.","journal-title":"Mol Cell Biol"},{"issue":"10","key":"1208_CR32","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1128\/MCB.01516-07","volume":"28","author":"LP Wu","year":"2008","unstructured":"Wu LP, Wang X, Li L, Zhao Y, Lu SL, Yu Y, et al. Histone deacetylase inhibitor depsipeptide activates silenced genes through decreasing both CpG and H3K9 methylation on the promoter. Mol Cell Biol. 2008;28(10):3219\u201335.","journal-title":"Mol Cell Biol"},{"issue":"1","key":"1208_CR33","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cell.2012.06.013","volume":"150","author":"MA Dawson","year":"2012","unstructured":"Dawson MA, Kouzarides T. Cancer epigenetics: from mechanism to therapy. Cell. 2012;150(1):12\u201327.","journal-title":"Cell"},{"issue":"4","key":"1208_CR34","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nrd1698","volume":"4","author":"JP Issa","year":"2005","unstructured":"Issa JP, Kantarjian HM, Kirkpatrick P. Azacitidine. Nat Rev Drug Discov. 2005;4(4):275\u20136.","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"1208_CR35","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1002\/cncr.21792","volume":"106","author":"H Kantarjian","year":"2006","unstructured":"Kantarjian H, Issa JP, Rosenfeld CS, Bennett JM, Albitar M, DiPersio J, et al. Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study. Cancer. 2006;106(8):1794\u2013803.","journal-title":"Cancer"},{"issue":"10","key":"1208_CR36","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1634\/theoncologist.12-10-1247","volume":"12","author":"BS Mann","year":"2007","unstructured":"Mann BS, Johnson JR, Cohen MH, Justice R, Pazdur R. FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma. Oncologist. 2007;12(10):1247\u201352.","journal-title":"Oncologist"},{"issue":"32","key":"1208_CR37","doi-asserted-by":"publisher","first-page":"5410","DOI":"10.1200\/JCO.2008.21.6150","volume":"27","author":"RL Piekarz","year":"2009","unstructured":"Piekarz RL, Frye R, Turner M, Wright JJ, Allen SL, Kirschbaum MH, et al. Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma. J Clin Oncol. 2009;27(32):5410\u20137.","journal-title":"J Clin Oncol"},{"issue":"2","key":"1208_CR38","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ejcb.2012.11.001","volume":"92","author":"M Culmes","year":"2012","unstructured":"Culmes M, Eckstein HH, Burgkart R, Nussler AK, Guenther M, Wagner E, et al. Endothelial differentiation of adipose-derived mesenchymal stem cells is improved by epigenetic modifying drug BIX-01294. Eur J Cell Biol. 2012;92(2):70\u20139.","journal-title":"Eur J Cell Biol"},{"issue":"23","key":"1208_CR39","doi-asserted-by":"publisher","first-page":"6520","DOI":"10.1158\/1078-0432.CCR-13-0877","volume":"19","author":"MA Salvador","year":"2013","unstructured":"Salvador MA, Wicinski J, Cabaud O, Toiron Y, Finetti P, Josselin E, et al. The histone deacetylase inhibitor abexinostat induces cancer stem cells differentiation in breast cancer with low Xist expression. Clin Cancer Res. 2013;19(23):6520\u201331.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"1208_CR40","first-page":"821","volume":"32","author":"I Svechnikova","year":"2008","unstructured":"Svechnikova I, Almqvist PM, Ekstrom TJ. HDAC inhibitors effectively induce cell type-specific differentiation in human glioblastoma cell lines of different origin. Int J Oncol. 2008;32(4):821\u20137.","journal-title":"Int J Oncol"},{"issue":"18","key":"1208_CR41","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.1182\/blood-2011-12-400580","volume":"119","author":"L Nygren","year":"2012","unstructured":"Nygren L, Baumgartner Wennerholm S, Klimkowska M, Christensson B, Kimby E, Sander B. Prognostic role of SOX11 in a population-based cohort of mantle cell lymphoma. Blood. 2012;119(18):4215\u201323.","journal-title":"Blood"},{"issue":"2","key":"1208_CR42","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/j.1365-2141.2008.07329.x","volume":"143","author":"X Wang","year":"2008","unstructured":"Wang X, Asplund AC, Porwit A, Flygare J, Smith CI, Christensson B, et al. The subcellular Sox11 distribution pattern identifies subsets of mantle cell lymphoma: correlation to overall survival. Br J Haematol. 2008;143(2):248\u201352.","journal-title":"Br J Haematol"},{"key":"1208_CR43","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1158\/0008-5472.CAN-09-3419","volume":"70","author":"V Fernandez","year":"2010","unstructured":"Fernandez V, Salamero O, Espinet B, Sole F, Royo C, Navarro A, et al. Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma. Cancer Res. 2010;70:1408\u201318. 2010\/02\/04 edn.","journal-title":"Cancer Res"},{"issue":"20","key":"1208_CR44","doi-asserted-by":"publisher","first-page":"5307","DOI":"10.1158\/0008-5472.CAN-12-1615","volume":"72","author":"A Navarro","year":"2012","unstructured":"Navarro A, Clot G, Royo C, Jares P, Hadzidimitriou A, Agathangelidis A, et al. Molecular subsets of mantle cell lymphoma defined by the IGHV mutational status and SOX11 expression have distinct biologic and clinical features. Cancer Res. 2012;72(20):5307\u201316.","journal-title":"Cancer Res"},{"issue":"10","key":"1208_CR45","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1038\/bjc.2013.176","volume":"108","author":"P Korkolopoulou","year":"2013","unstructured":"Korkolopoulou P, Levidou G, El-Habr EA, Adamopoulos C, Fragkou P, Boviatsis E, et al. Sox11 expression in astrocytic gliomas: correlation with nestin\/c-Met\/IDH1-R132H expression phenotypes, p-Stat-3 and survival. Br J Cancer. 2013;108(10):2142\u201352.","journal-title":"Br J Cancer"},{"issue":"24","key":"1208_CR46","doi-asserted-by":"publisher","first-page":"5247","DOI":"10.1182\/blood-2010-04-280149","volume":"116","author":"I Velichutina","year":"2010","unstructured":"Velichutina I, Shaknovich R, Geng H, Johnson NA, Gascoyne RD, Melnick AM, et al. EZH2-mediated epigenetic silencing in germinal center B cells contributes to proliferation and lymphomagenesis. Blood. 2010;116(24):5247\u201355.","journal-title":"Blood"},{"issue":"7078","key":"1208_CR47","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/nature04431","volume":"439","author":"E Vire","year":"2006","unstructured":"Vire E, Brenner C, Deplus R, Blanchon L, Fraga M, Didelot C, et al. The Polycomb group protein EZH2 directly controls DNA methylation. Nature. 2006;439(7078):871\u20134.","journal-title":"Nature"},{"key":"1208_CR48","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/1471-2407-13-215","volume":"13","author":"BM Muller","year":"2013","unstructured":"Muller BM, Jana L, Kasajima A, Lehmann A, Prinzler J, Budczies J, et al. Differential expression of histone deacetylases HDAC1, 2 and 3 in human breast cancer\u2013overexpression of HDAC2 and HDAC3 is associated with clinicopathological indicators of disease progression. BMC Cancer. 2013;13:215.","journal-title":"BMC Cancer"},{"issue":"4-5","key":"1208_CR49","first-page":"245","volume":"5","author":"C Van Lint","year":"1996","unstructured":"Van Lint C, Emiliani S, Verdin E. The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation. Gene Expr. 1996;5(4-5):245\u201353.","journal-title":"Gene Expr"},{"issue":"2","key":"1208_CR50","first-page":"151","volume":"2","author":"KB Glaser","year":"2003","unstructured":"Glaser KB, Staver MJ, Waring JF, Stender J, Ulrich RG, Davidsen SK. Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors: defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma cell lines. Mol Cancer Ther. 2003;2(2):151\u201363.","journal-title":"Mol Cancer Ther"},{"key":"1208_CR51","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/1755-8794-2-67","volume":"2","author":"MJ LaBonte","year":"2009","unstructured":"LaBonte MJ, Wilson PM, Fazzone W, Groshen S, Lenz HJ, Ladner RD. DNA microarray profiling of genes differentially regulated by the histone deacetylase inhibitors vorinostat and LBH589 in colon cancer cell lines. BMC Med Genomics. 2009;2:67.","journal-title":"BMC Med Genomics"},{"issue":"9","key":"1208_CR52","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1093\/nar\/gkn162","volume":"36","author":"P Dy","year":"2008","unstructured":"Dy P, Penzo-Mendez A, Wang H, Pedraza CE, Macklin WB, Lefebvre V. The three SoxC proteins\u2013Sox4, Sox11 and Sox12\u2013exhibit overlapping expression patterns and molecular properties. Nucleic Acids Res. 2008;36(9):3101\u201317.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"1208_CR53","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.ccr.2013.04.020","volume":"23","author":"N Tiwari","year":"2013","unstructured":"Tiwari N, Tiwari VK, Waldmeier L, Balwierz PJ, Arnold P, Pachkov M, et al. Sox4 is a master regulator of epithelial-mesenchymal transition by controlling Ezh2 expression and epigenetic reprogramming. Cancer Cell. 2013;23(6):768\u201383.","journal-title":"Cancer Cell"},{"issue":"3","key":"1208_CR54","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.molcel.2014.06.005","volume":"55","author":"EM Riising","year":"2014","unstructured":"Riising EM, Comet I, Leblanc B, Wu X, Johansen JV, Helin K. Gene silencing triggers polycomb repressive complex 2 recruitment to CpG islands genome wide. Mol Cell. 2014;55(3):347\u201360.","journal-title":"Mol Cell"},{"issue":"1","key":"1208_CR55","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.canlet.2008.08.016","volume":"277","author":"O Witt","year":"2009","unstructured":"Witt O, Deubzer HE, Milde T, Oehme I. HDAC family: What are the cancer relevant targets? Cancer Lett. 2009;277(1):8\u201321.","journal-title":"Cancer Lett"},{"issue":"2","key":"1208_CR56","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/561","volume":"19","author":"PL Jones","year":"1998","unstructured":"Jones PL, Veenstra GJ, Wade PA, Vermaak D, Kass SU, Landsberger N, et al. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet. 1998;19(2):187\u201391.","journal-title":"Nat Genet"},{"issue":"5","key":"1208_CR57","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1158\/1541-7786.MCR-07-0330","volume":"6","author":"Q Zhou","year":"2008","unstructured":"Zhou Q, Agoston AT, Atadja P, Nelson WG, Davidson NE. Inhibition of histone deacetylases promotes ubiquitin-dependent proteasomal degradation of DNA methyltransferase 1 in human breast cancer cells. Mol Cancer Res. 2008;6(5):873\u201383.","journal-title":"Mol Cancer Res"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-015-1208-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1208-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1208-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1208-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T10:34:47Z","timestamp":1630578887000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-015-1208-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,12]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1208"],"URL":"https:\/\/doi.org\/10.1186\/s12885-015-1208-y","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,12]]},"assertion":[{"value":"14 July 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"273"}}